Non-invasive VNS for Parkinson's Gait
NCT: NCT06562569 · RECRUITING
Brief Summary
More than 110,000 US Veterans living with Parkinson's disease (PD) currently receive PD-related care and services from the VA. Fall prevention is a priority for Veterans living PD. Gait disturbances are a major cause for functional dependence and the largest risk factor for falls, institutionalization, and death in PD. This SPiRE addresses the need to advance nonpharmacological rehabilitative health care of Veterans and maximizing functional outcomes by developing a non-invasive, neuromodulatory transcutaneous cervical Vagal Nerve Stimulation as an at-home intervention to improve gait and balance. This pilot clinical trial will assist with future efforts and priorities of the VA to prolong independent living and quality of life by minimizing gait and balance dysfunction experienced by Veterans living with PD.
Frequently Asked Questions
What is Non-invasive VNS for Parkinson's Gait?
Non-invasive VNS for Parkinson's Gait is a clinical trial registered under NCT06562569. Current status: RECRUITING.
What is the status of NCT06562569?
The current status of NCT06562569 (Non-invasive VNS for Parkinson's Gait) is: RECRUITING.
When did Non-invasive VNS for Parkinson's Gait start?
Non-invasive VNS for Parkinson's Gait started on 2026-03-01.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.